Editor’s blog Sunday 30 May 2010: Weekly publication of hospital infection rates ahoy!
Kingsley Amis once famously wrote in July 1960's Encounter magazine about higher
education, "more will mean worse&
Editor’s blog Thursday 27 May 2010: Update on SHA assurance scheme reports
You've seen the recent announcement that SHAs are to be abolished
[http://www.healthpolicyinsight.com/?q=node/522]
Editor's blog Friday 28 May 2010: More on HSMR measures
Hello. Hope you're well and looking forward to a bank holiday weekend full of
high-profile policy announcements (just
Editor’s blog Thursday 27 May 2010: England's only non-AfC trust to shed jobs: Southend of the pier show for 400 staff
Morning, all.
Southend University Hospitals NHS FT has previously been somewhat famous in NHS
managementland as the only foundation trust
Editor’s blog Thursday 27 May 2010: The baker's double-dozen: 26 policy questions for Health Secretary Andrew Lansley
With acknowldgement to HSJ editor Alastair McLellan for the inspiration (i.e. I
nicked his concept
[http://www.hsj.co.
Editor’s blog Thursday 27 May 2010: The baker's double-dozen: 26 policy questions for Health Secretary Andrew Lansley
With acknowldgement to HSJ editor Alastair McLellan for the inspiration (i.e. I
nicked his concept
[http://www.hsj.co.
Editor’s blog Wednesday 26 May 2010: Commons health select committee chair to be a Conservative
It's not unduly newsworthy, but interesting to note that the usually reliable
Iain Dale's Diary blog
Editor’s blog Wednesday 26 May 2010: London SHA is falling down
NHS London chair Sir Richard Sykes has resigned over Health Secretary Andrew
Lansley's over-ruling of the Healthcare For
Editor’s blog Wednesday 26 May 2010: Change at the top for the Confed
Good evening. Bit manic today.
Tomorrow, we will discuss how much pro-market people dislike actual capitalism.
For today, you may
The Maynard Doctrine: £200 million National Cancer Drugs Fund - nice price for Big Pharma; nasty for NICE
Professor Alan Maynard reviews the reasoning behind government proposals for
spending another £200 million on new cancer drugs not recommended
